2023-05-22 08:06
(6 d 13:18 ago)

Posting: # 23563
Views: 149

 regulatory guideline [Regulatives / Guidelines]

In bioequivalence study if any adverse event is ongoing; we can collect safety sample or end study sample before completion of adverse event. if any reference guideline pls show
UA Flag
 Admin contact
22,614 posts in 4,740 threads, 1,609 registered users;
25 visitors (0 registered, 25 guests [including 11 identified bots]).
Forum time: 21:25 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz